Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026)
Incannex Healthcare's (IXHL) quarterly Non Operating Income came in at $165000.0 in Q1 2026, down 84.06% year-on-year from $1.0 million in Q1 2025, and down 65.19% quarter-over-quarter from $474000.0 in Q4 2025.
Incannex Healthcare (IXHL) Non Operating Income (2022 - 2026) Analysis & Trends
Incannex Healthcare has disclosed Non Operating Income across 5 years of filings, most recently posting $165000.0 for Q1 2026.
- Non Operating Income for Q1 2026 came in at $165000.0, down 84.06% year-over-year; the trailing twelve-month figure through Mar 2026 was -$23.0 million (down 637.02% YoY), and the FY2025 annual result was -$23.1 million, down 298.9% from the prior year.
- Non Operating Income came in at $165000.0 for Q1 2026 at Incannex Healthcare, down from $474000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $4.2 million in Q3 2023 to a low of -$24.1 million in Q2 2025.
- The 5-year median for Non Operating Income is $597500.0 (2022), against an average of -$688857.1.
- Across the five-year window, Non Operating Income surged 16465.0% in 2024 and slumped 826.68% in 2025, its largest moves.
- Incannex Healthcare's Non Operating Income stood at $721000.0 in 2022, then jumped by 280.31% to $2.7 million in 2023, then sank by 132.46% to -$890000.0 in 2024, then soared by 153.26% to $474000.0 in 2025, then sank by 65.19% to $165000.0 in 2026.
- The last three Non Operating Income figures came in at $165000.0 (Q1 2026), $474000.0 (Q4 2025), and $387000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Incannex Healthcare | 45.81 Mn | 45.81 Mn | - | 165,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 165,000.00 |
| Dec 31, 2025 | 474,000.00 |
| Sep 30, 2025 | 387,000.00 |
| Jun 30, 2025 | -24.08 Mn |
| Mar 31, 2025 | 1.04 Mn |
| Dec 31, 2024 | -890,000.00 |
| Sep 30, 2024 | 834,000.00 |
| Jun 30, 2024 | 3.31 Mn |
| Mar 31, 2024 | 1.38 Mn |
| Dec 31, 2023 | 2.74 Mn |
| Sep 30, 2023 | 4.17 Mn |
| Jun 30, 2023 | 20,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 721,000.00 |